Clinical Trial Update: Mutation Analysis and Copy Number Changes of KRAS and BRAF Gene in Taiwanese Cases of Biliary Tact Adenocarcinoma

View source ↗

Summary

A clinical trial update describing mutation analysis and copy number changes in KRAS and BRAF genes in Taiwanese biliary tract adenocarcinoma cases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Adenocarcinoma

Snippet

Sponsor: Far Eastern Memorial Hospital | Conditions: Biliary Tract Adenocarcinoma | Status: UNKNOWN